19.05
price down icon0.63%   -0.12
after-market Dopo l'orario di chiusura: 18.96 -0.09 -0.47%
loading
Precedente Chiudi:
$19.17
Aprire:
$19.04
Volume 24 ore:
377.26K
Relative Volume:
1.06
Capitalizzazione di mercato:
$764.54M
Reddito:
-
Utile/perdita netta:
$-102.09M
Rapporto P/E:
-18.14
EPS:
-1.05
Flusso di cassa netto:
$-108.72M
1 W Prestazione:
-0.63%
1M Prestazione:
+47.67%
6M Prestazione:
+84.95%
1 anno Prestazione:
+486.15%
Intervallo 1D:
Value
$18.86
$19.62
Intervallo di 1 settimana:
Value
$18.78
$19.90
Portata 52W:
Value
$3.3034
$26.18

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
Nome
Dbv Technologies Adr
Name
Telefono
33(0)155427878
Name
Indirizzo
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
Dipendente
117
Name
Cinguettio
@dbvtechnologies
Name
Prossima data di guadagno
2024-07-29
Name
Ultimi documenti SEC
Name
DBVT's Discussions on Twitter

Confronta DBVT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
19.05 769.36M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.13 115.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
776.31 81.12B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.17 52.54B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
839.99 51.78B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.12 37.12B 447.02M -1.18B -906.14M -6.1812

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-15 Iniziato Cantor Fitzgerald Overweight
2025-12-03 Iniziato Guggenheim Buy
2025-05-29 Ripresa Goldman Sell
2023-01-04 Aggiornamento Societe Generale Hold → Buy
2022-12-16 Downgrade Goldman Neutral → Sell
2022-05-10 Downgrade Goldman Buy → Neutral
2021-09-14 Aggiornamento Societe Generale Hold → Buy
2021-01-22 Downgrade Societe Generale Hold → Sell
2020-11-02 Aggiornamento Societe Generale Sell → Hold
2020-08-06 Downgrade Societe Generale Buy → Sell
2020-08-05 Reiterato H.C. Wainwright Buy
2020-03-17 Downgrade Stifel Buy → Hold
2020-01-09 Aggiornamento Stifel Hold → Buy
2019-12-16 Iniziato Citigroup Buy
2019-09-05 Ripresa Morgan Stanley Equal-Weight
2019-06-17 Iniziato Goldman Buy
2018-12-20 Downgrade Barclays Overweight → Equal Weight
2018-12-20 Downgrade BofA/Merrill Buy → Underperform
2018-12-20 Downgrade Jefferies Buy → Hold
2018-12-20 Downgrade Stifel Buy → Hold
2017-10-31 Aggiornamento Societe Generale Sell → Hold
2017-10-24 Downgrade Societe Generale Buy → Sell
2017-10-23 Downgrade Morgan Stanley Overweight → Equal-Weight
2017-06-23 Iniziato Deutsche Bank Buy
2017-03-16 Aggiornamento Societe Generale Hold → Buy
2016-09-26 Iniziato JMP Securities Mkt Outperform
2015-12-03 Iniziato Barclays Overweight
2015-10-23 Iniziato BofA/Merrill Buy
Mostra tutto

Dbv Technologies Adr Borsa (DBVT) Ultime notizie

pulisher
Dec 31, 2025

How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next? - Benzinga

Dec 31, 2025
pulisher
Dec 28, 2025

The Insider Report: A Tape Fitting for the Holiday - Sahm

Dec 28, 2025
pulisher
Dec 23, 2025

European ADRs Started The Week Higher, Led By Biotech - Finimize

Dec 23, 2025
pulisher
Dec 23, 2025

Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Dec 23, 2025
pulisher
Dec 23, 2025

Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm

Dec 23, 2025
pulisher
Dec 23, 2025

DBV Technologies (NASDAQ:DBVT) Shares Gap Down on Insider Selling - Defense World

Dec 23, 2025
pulisher
Dec 21, 2025

H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result - Finviz

Dec 21, 2025
pulisher
Dec 21, 2025

Stock Market Today 21.12.2025 - ts2.tech

Dec 21, 2025
pulisher
Dec 20, 2025

HC Wainwright Boosts Earnings Estimates for DBV Technologies - Defense World

Dec 20, 2025
pulisher
Dec 19, 2025

DBV Technologies (NASDAQ:DBVT) Given New $45.00 Price Target at Citizens Jmp - Defense World

Dec 19, 2025
pulisher
Dec 19, 2025

DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 19, 2025
pulisher
Dec 19, 2025

HC Wainwright Has Positive Outlook for DBVT FY2026 Earnings - Defense World

Dec 19, 2025
pulisher
Dec 18, 2025

Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Dec 18, 2025
pulisher
Dec 18, 2025

DBV Technologies (NASDAQ:DBVT) Sets New 12-Month High on Analyst Upgrade - Defense World

Dec 18, 2025
pulisher
Dec 17, 2025

European Stocks On Wall Street Delivered Modest Moves For Investors - Finimize

Dec 17, 2025
pulisher
Dec 17, 2025

Crude Oil Rises Over 1%; General Mills Earnings Top Views - Benzinga

Dec 17, 2025
pulisher
Dec 17, 2025

Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday - Benzinga

Dec 17, 2025
pulisher
Dec 17, 2025

Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success By Investing.com - ca.investing.com

Dec 17, 2025
pulisher
Dec 17, 2025

Pre Market Movers: DBVT, YCBD, KYTX Set The Pace - RTTNews

Dec 17, 2025
pulisher
Dec 17, 2025

Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success - Investing.com UK

Dec 17, 2025
pulisher
Dec 17, 2025

DBV Technologies receive positive results in key study with peanut patch - medwatch.com

Dec 17, 2025
pulisher
Dec 17, 2025

Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 17, 2025
pulisher
Dec 17, 2025

Cantor Fitzgerald Upgrades DBV Technologies (NASDAQ:DBVT) to “Strong-Buy” - Defense World

Dec 17, 2025
pulisher
Dec 16, 2025

DBV Technologies stock soars after positive Phase 3 trial results - Investing.com

Dec 16, 2025
pulisher
Dec 16, 2025

DBV Technologies Reports Positive Phase 3 Trial Results - TipRanks

Dec 16, 2025
pulisher
Dec 16, 2025

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - The Manila Times

Dec 16, 2025
pulisher
Dec 16, 2025

DBV Technologies Announces Positive Topline Results from - GlobeNewswire

Dec 16, 2025
pulisher
Dec 16, 2025

Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing - Sahm

Dec 16, 2025
pulisher
Dec 16, 2025

DBV Technologies (NASDAQ:DBVT) Shares Gap DownTime to Sell? - MarketBeat

Dec 16, 2025
pulisher
Dec 15, 2025

Micron Technology To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

This SiTime Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

DBV Technologies stock price target raised to $35 from $20 at H.C. Wainwright - Investing.com

Dec 15, 2025
pulisher
Dec 15, 2025

DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Nigeria

Dec 15, 2025
pulisher
Dec 15, 2025

DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald - Investing.com

Dec 15, 2025
pulisher
Dec 11, 2025

European Companies Trading In The US Notched Gains This Week - Finimize

Dec 11, 2025
pulisher
Dec 09, 2025

What is DBV Technologies ADR (DBVT) Stock Return on Shareholders’ Capital? - setenews.com

Dec 09, 2025
pulisher
Dec 09, 2025

Are Smart Investors Making the Right Decision? Snow Lake Resources Ltd (LITM) - setenews.com

Dec 09, 2025
pulisher
Dec 09, 2025

Vivo Capital LLC Takes Position in DBV Technologies S.A. $DBVT - MarketBeat

Dec 09, 2025
pulisher
Dec 07, 2025

Total assets of DBV Technologies SA Sponsored ADR – LSX:A40WEX - TradingView

Dec 07, 2025
pulisher
Dec 05, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated at Guggenheim - Defense World

Dec 05, 2025
pulisher
Dec 03, 2025

Check Out Netskope Inc (NTSK)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 03, 2025
pulisher
Dec 03, 2025

Taking on analysts’ expectations and winning: DBV Technologies ADR (DBVT) - setenews.com

Dec 03, 2025
pulisher
Dec 03, 2025

DBV Technologies stock initiated with Buy rating at Guggenheim - Investing.com

Dec 03, 2025
pulisher
Nov 28, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm

Nov 28, 2025
pulisher
Nov 27, 2025

Healthy Upside Potential: Safe Pro Group Inc (SPAI) - Setenews

Nov 27, 2025
pulisher
Nov 27, 2025

European Drugmakers And Banks Put ADRs In The Green - Finimize

Nov 27, 2025
pulisher
Nov 24, 2025

DBV Technologies S.A. (NASDAQ:DBVT) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Nov 24, 2025
pulisher
Nov 19, 2025

RFK Jr Rejects Early Exposure Theory On Rising Peanut Allergies, Says Aluminum-Based Vaccines Are The Reason - Sahm

Nov 19, 2025
pulisher
Nov 15, 2025

European ADRs Slip As Gains And Losses Balance Out - Finimize

Nov 15, 2025

Dbv Technologies Adr Azioni (DBVT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
Capitalizzazione:     |  Volume (24 ore):